Catherine Diefenbach

The bone marrow microenvironment at single-cell resolution

Anastasia N. Tikhonova, Igor Dolgalev, Hai Hu et al. · Nature · 2019 · 903 citations · Full text

Medicine, Biological Microenvironments, Single-cell Analysis +2

Phase I Trial of Overlapping Long Peptides from a Tumor Self-Antigen and Poly-ICLC Shows Rapid Induction of Integrated Immune Response in Ovarian Cancer Patients

Paul Sabbatini, Takemasa Tsuji, Luis Ferran et al. · Clinical Cancer Research · 2012 · 272 citations

Polatuzumab vedotin or pinatuzumab vedotin plus rituximab in patients with relapsed or refractory non-Hodgkin lymphoma: final results from a phase 2 randomised study (ROMULUS)

Franck Morschhauser, Ian W. Flinn, Ranjana H. Advani et al. · The Lancet Haematology · 2019 · 243 citations · Full text

Lymphoid Neoplasia, Pinatuzumab Vedotin, Medicine +9

Phase I Study of the Novel Investigational NEDD8-Activating Enzyme Inhibitor Pevonedistat (MLN4924) in Patients with Relapsed/Refractory Multiple Myeloma or Lymphoma

Jatin J. Shah, Andrzej Jakubowiak, Owen A. O’Connor et al. · Clinical Cancer Research · 2015 · 188 citations · Full text

A genome-scale screen for synthetic drivers of T cell proliferation

Mateusz Legut, Zoran Gajic, Maria Guarino et al. · Nature · 2022 · 173 citations · Full text

Human Cell, Medicine, T-regulatory Cell +9